Gene Panel Market, by Technique (Amplicon-Based and Hybridization-Based), by Design (Predesigned Gene Panels and Customized Gene Panels), by Application (Pharmacogenetics, Diagnosis of Congenital Disorders, Cancer Risk Assessment, and Others), by End User

Gene Panel Market, by Technique (Amplicon-Based and Hybridization-Based), by Design (Predesigned Gene Panels and Customized Gene Panels), by Application (Pharmacogenetics, Diagnosis of Congenital Disorders, Cancer Risk Assessment, and Others), by End User (Research and Academic Institutes, Hospital and Diagnostic Laboratories, and Biotechnology and Pharmaceutical Companies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

Gene panels are specialized diagnostic tools used to assess multiple genes at once for mutations related to diseases such as cancer, cardiomyopathy, and others. Gene panels enable the users to obtain results at a reduced cost and time. Gene panels are useful in sequencing genes such as BRCA1 to detect mutations that may lead to cancer. DNA sample from blood, muscle or saliva can be used in gene panel testing. Low muscle tone, epilepsy, and short stature are few conditions which can be diagnosed using gene panel tests. Rapid research in DNA sequencing technology has led to the advancement of gene panels making them more efficient, economical, and flexible.

Market Dynamics

Market players are conducting clinical trials for exploring the potential uses of gene panels for diagnosis of a number of genetic disorders, which could contribute to the growth of the gene panel market over the forecast period. For instance, in November 2021 Bordeaux University Hospital, France, initiated an observational clinical study for implementation of a next generation sequencing gene panel for diagnosis of incomplete forms of albinism. This study identifies the usability of NGS gene panel in overcoming the challenges faced in identification of ocular albinism as it does not show many observable ophthalmic signs. This study comprises of 100 participants and is expected to be completed by March 2022.

Market players are focusing on launch of products, which is expected to strengthen their position in the global gene panel market. For instance, in June 2018, Thermo Fisher Scientific Inc., an American scientific instrumentation company, launched Ion AmpliSeq HD technology as an amplicon-based library for targeted next gene sequencing, it enables the user to customize one’s own gene panel by selecting the appropriate gene sequences from the gene library which are associated with a particular disease and detect low-frequency alleles in tumor RNA or DNA.

Key features of the study:
This report provides an in-depth analysis of global gene panel market, provides market size (US$ Million), and compound annual growth rate (CAGR %) for the forecast period (2022-2028), considering 2021 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrix for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategies adopted by the leading players
It profiles leading players in the global gene panel market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies, and future plans
Key companies covered as a part of this study include Thermo Fisher Scientific Inc., BGI, GENEWIZ, Inc., GATC Biotech, Novogene Co., Ltd., QIAGEN, Integrated DNA Technologies, Inc., Illumina Inc., Agilent Technologies, Inc., Eurofins Scientific, F. Hoffmann-La Roche Ltd, Personalis Inc., GeneDx Inc., and Invitae Corporation
Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launch, technology up-gradation, market expansion, and marketing tactics
The global gene panel market report caters to various stakeholders in this industry including investors, suppliers, manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision making through various strategy matrices used in analyzing the gene panel market
Detailed Segmentation:
Global Gene Panel Market, By Technique:
Amplicon-Based
Hybridization-Based
Global Gene Panel Market, By Design:
Predesigned Gene Panels
Customized Gene Panels
Global Gene Panel Market, By Application:
Pharmacogenetics
Diagnosis of Congenital Disorders
Cancer Risk Assessment
Others
Global Gene Panel Market, By End User:
Research and Academic Institutes
Hospital and Diagnostic Laboratories
Biotechnology and Pharmaceutical Companies
Global Gene Panel Market, By Region:
North America
By Technique:
Amplicon-Based
Hybridization-Based
By Design:
Predesigned Gene Panels
Customized Gene Panels
By Application:
Pharmacogenetics
Diagnosis of Congenital Disorders
Cancer Risk Assessment
Others
By End User:
Research and Academic Institutes
Hospital and Diagnostic Laboratories
Biotechnology and Pharmaceutical Companies
By Country:
U.S.
Canada
Latin America
By Technique:
Amplicon-Based
Hybridization-Based
By Design:
Predesigned Gene Panels
Customized Gene Panels
By Application:
Pharmacogenetics
Diagnosis of Congenital Disorders
Cancer Risk Assessment
Others
By End User:
Research and Academic Institutes
Hospital and Diagnostic Laboratories
Biotechnology and Pharmaceutical Companies
By Country:
Brazil
Mexico
Argentina
Rest of Latin America
Europe
By Technique:
Amplicon-Based
Hybridization-Based
By Design:
Predesigned Gene Panels
Customized Gene Panels
By Application:
Pharmacogenetics
Diagnosis of Congenital Disorders
Cancer Risk Assessment
Others
By End User:
Research and Academic Institutes
Hospital and Diagnostic Laboratories
Biotechnology and Pharmaceutical Companies
By Country:
U.K.
Germany
Italy
Spain
France
Russia
Rest of Europe
Asia Pacific
By Technique:
Amplicon-Based
Hybridization-Based
By Design:
Predesigned Gene Panels
Customized Gene Panels
By Application:
Pharmacogenetics
Diagnosis of Congenital Disorders
Cancer Risk Assessment
Others
By End User:
Research and Academic Institutes
Hospital and Diagnostic Laboratories
Biotechnology and Pharmaceutical Companies
By Country
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific

Middle East
By Technique:
Amplicon-Based
Hybridization-Based
By Design:
Predesigned Gene Panels
Customized Gene Panels
By Application:
Pharmacogenetics
Diagnosis of Congenital Disorders
Cancer Risk Assessment
Others
By End User:
Research and Academic Institutes
Hospital and Diagnostic Laboratories
Biotechnology and Pharmaceutical Companies
By Country:
GCC
Israel
Rest of Middle East
Africa
By Technique:
Amplicon-Based
Hybridization-Based
By Design:
Predesigned Gene Panels
Customized Gene Panels
By Application:
Pharmacogenetics
Diagnosis of Congenital Disorders
Cancer Risk Assessment
Others
By End User:
Research and Academic Institutes
Hospital and Diagnostic Laboratories
Biotechnology and Pharmaceutical Companies
By Country/Region:
South Africa
Central Africa
North Africa
Company Profiles
Thermo Fisher Scientific Inc.*
Company Overview
Product Portfolio
Financial Performance
Recent Highlights
Strategies
BGI
GENEWIZ, Inc.
GATC Biotech
Novogene Co., Ltd.
QIAGEN
Integrated DNA Technologies, Inc.
Illumina, Inc.
Agilent Technologies, Inc.
Eurofins Scientific
F. Hoffmann-La Roche Ltd
Personalis Inc.
GeneDx Inc.
Invitae Corporation
“*” marked represents similar segmentation in other categories in the respective section.